1Neural and Müller glial adaptation of the retina to photoreceptor degenerationHenri O.Leinonen，Edward Bull，Zhongjie FuReviews701-707
2Targeting neuroinflammation in Alzheimer 's disease: from mechanisms to clinical applicationsZi-Zhen Si，Chen-Jun Zou，Xi Mei，Xiao-Fang Li，Hu Luo，Yao Shen，Jun Hu，Xing-Xing Li，Lun Wu，Yu LiuReviews708-715
3MicroRNAs as potential biomarkers in temporal lobe epilepsy and mesial temporal lobe epilepsyBridget Martinez，Philip V.PeplowReviews716-726
4Agomelatine: a potential novel approach for the treatment of memory disorder in neurodegenerative diseaseQiang Su，Tian Li，Guo-Wei Liu，Yan-Li Zhang，Jun-Hong Guo，Zhao-Jun Wang，Mei-Na Wu，Jin-Shun QiReviews727-733
5MicroRNAs: protective regulators for neuron growth and developmentZhi-Xuan Ma，Zhen Liu，Hui-Hui Xiong，Zong-Pu Zhou，Li-Si Ouyang，Fu-Kang Xie，Ya-Mei Tang，Zhong-Dao Wu，Ying FengReviews734-745
6Novel insights into the mechanism of reactive oxygen species-mediated neurodegenerationShuji Wakatsuki，Toshiyuki ArakiReviews746-749
7In vivo astrocyte-to-neuron reprogramming for central nervous system regeneration: a narrative reviewZuliyaer Talifu，Jia-Yi Liu，Yun-Zhu Pan，Han Ke，Chun-Jia Zhang，Xin Xu，Feng Gao，Yan Yu，Liang-Jie Du，Jian-Jun LiReviews750-755
8Potential physiological and pathological roles for axonal ryanodine receptorsDavid P.StirlingReviews756-759
9Melatonin, tunneling nanotubes, mesenchymal cells, and tissue regenerationFrancesca Luchetti，Silvia Carloni，Maria G.Nasoni，Russel J.Reiter，Walter BalduiniReviews760-762
10Emerging roles of GPR109A in regulation of neuroinflammation in neurological diseases and painKyle Taing，Lawrence Chen，Han-Rong WengReviews763-768
11Roles of constitutively secreted extracellular chaperones in neuronal cell repair and regenerationSandeep Satapathy，Mark R.WilsonReviews769-772
12Intranasal nerve growth factor for prevention and recovery of the outcomes of traumatic brain injuryLuigi Manni，Giorgio Conti，Antonio Chiaretti，Marzia SoligoReviews773-778
13Altered O-GlcNAcylation and mitochondrial dysfunction, a molecular link between brain glucose dysregulation and sporadic Alzheimer 's diseaseChia-Wei Huang，Nicholas C.Rust，Hsueh-Fu Wu，Gerald W.HartReviews779-783
14Signaling interactions among neurons impact cell fitness and death in Alzheimer 's diseaseCatherine Yeates，Prajakta Deshpande，Madhuri Kango-Singh，Amit SinghReviews784-789
15Pathophysiological mechanisms of chronic compressive spinal cord injury due to vascular eventsZhen-Xiao Ren，Jing-Hui Xu，Xing Cheng，Gui-Xing Xu，Hou-Qing LongReviews790-796
16Next generation drug connectivity mapping for acquiring therapeutic agents to differentially regulate myelinationKasum Azim，Andrea Domenico Rivera，Arthur Morgan ButtPerspectives797-798
17Acute and long-term changes in blood flow after ischemic stroke: challenges and opportunitiesDino Premilovac，Brad A.SutherlandPerspectives799-800
18Pathology-induced NG2 proteoglycan expression in microgliaErika Meyer，Anja SchellerPerspectives801-802
19Nilotinib: from animal-based studies to clinical investigation in Alzheimer 's disease patientsAnnalisa Nobili，Marcello D'Amelio，Maria Teresa ViscomiPerspectives803-804
20Multi-targeted anti-inflammatory drugs for the treatment of neurological disordersAustin Lui，Omar Alzayat，Timothy Do，David Perekopskiy，Meghan Gann，Taiseer Saad Elgokhy，Jie Gao，DaZhi LiuPerspectives805-806
